Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Marmion

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Chemical Reviews|January 15, 2019
Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?Reece G Kenny, Celine J Marmion
The British Journal of Ophthalmology|February 1, 1976
A clinical evaluation of the applanation pneumatonographM R Jain, V J Marmion
Journal of Neural Transmission (Vienna, Austria : 1996)|April 24, 2017
α-Synuclein nonhuman primate models of Parkinson's diseaseDavid J Marmion, Jeffrey H Kordower
Journal of the Royal Society of Medicine|May 2, 2002
The death of ClaudiusV J Marmion, T E J Wiedemann
Modern Problems in Ophthalmology|January 1, 1976
Genetic correlation of diabetic exudative retinopathyV J Marmion, S Yurdakul, E A Keely
Chemical Communications (Cambridge, England)|November 4, 2009
A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activityDarren Griffith, Maria P Morgan, Celine J Marmion
Anti-Cancer Agents in Medicinal Chemistry|April 13, 2010
Enzyme inhibition as a key target for the development of novel metal-based anti-cancer therapeuticsDarren Griffith, James P Parker, Celine J Marmion
Journal of Neural Transmission (Vienna, Austria : 1996)|October 6, 2021
A historical review of multiple system atrophy with a critical appraisal of cellular and animal modelsDavid J Marmion, Wouter Peelaerts, Jeffrey H Kordower
Chemical Communications (Cambridge, England)|September 21, 2002
Ruthenium(III) readily abstracts NO from L-arginine, the physiological precursor to NO, in the presence of H2O2. A remarkably simple model system for NO synthasesC J Marmion, T Murphy, K B Nolan
Metallomics : Integrated Biometal Science|November 17, 2015
Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancerJames P Parker, Ziga Ude, Celine J Marmion
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Chemical Reviews|January 15, 2019
Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?Reece G Kenny, Celine J Marmion
The British Journal of Ophthalmology|February 1, 1976
A clinical evaluation of the applanation pneumatonographM R Jain, V J Marmion
Journal of Neural Transmission (Vienna, Austria : 1996)|April 24, 2017
α-Synuclein nonhuman primate models of Parkinson's diseaseDavid J Marmion, Jeffrey H Kordower
Journal of the Royal Society of Medicine|May 2, 2002
The death of ClaudiusV J Marmion, T E J Wiedemann
Modern Problems in Ophthalmology|January 1, 1976
Genetic correlation of diabetic exudative retinopathyV J Marmion, S Yurdakul, E A Keely
Chemical Communications (Cambridge, England)|November 4, 2009
A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activityDarren Griffith, Maria P Morgan, Celine J Marmion
Anti-Cancer Agents in Medicinal Chemistry|April 13, 2010
Enzyme inhibition as a key target for the development of novel metal-based anti-cancer therapeuticsDarren Griffith, James P Parker, Celine J Marmion
Journal of Neural Transmission (Vienna, Austria : 1996)|October 6, 2021
A historical review of multiple system atrophy with a critical appraisal of cellular and animal modelsDavid J Marmion, Wouter Peelaerts, Jeffrey H Kordower
Chemical Communications (Cambridge, England)|September 21, 2002
Ruthenium(III) readily abstracts NO from L-arginine, the physiological precursor to NO, in the presence of H2O2. A remarkably simple model system for NO synthasesC J Marmion, T Murphy, K B Nolan
Metallomics : Integrated Biometal Science|November 17, 2015
Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancerJames P Parker, Ziga Ude, Celine J Marmion
Pageof 9